List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 223 studies with search of:   United States, Alaska
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Recruiting Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Procedure: chromogenic in situ hybridization;   Procedure: fluorescent antibody technique;   Procedure: gene expression analysis;   Procedure: immunohistochemistry staining method;   Procedure: laboratory biomarker analysis;   Procedure: matrix-assisted laser desorption/ionization time of flight mass spectrometry;   Procedure: mutation analysis;   Procedure: polymerase chain reaction;   Procedure: polymorphism analysis;   Procedure: study of high risk factors;   Procedure: study of socioeconomic and demographic variables
22 Active, not recruiting Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas
Condition: Pancreatic Cancer
Interventions: Drug: cetuximab;   Drug: gemcitabine hydrochloride
23 Completed Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Condition: Anal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: mitomycin C;   Procedure: radiation therapy
24 Active, not recruiting Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: tamoxifen citrate;   Procedure: adjuvant therapy;   Procedure: radiation therapy
25 Recruiting Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery
Condition: Kidney Cancer
Interventions: Drug: placebo;   Drug: sorafenib tosylate;   Drug: sunitinib malate
26 Recruiting Combination Chemotherapy, Rituximab, and Bevacizumab in Treating Older Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: bevacizumab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: rituximab;   Drug: vincristine sulfate
27 Recruiting Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Conditions: Breast Cancer;   Cancer-Related Problem/Condition
Interventions: Drug: cyclophosphamide;   Drug: goserelin
28 Active, not recruiting Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: cetuximab;   Drug: paclitaxel
29 Recruiting Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: placebo
30 Active, not recruiting Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
Condition: Prostate Cancer
Intervention: Procedure: radiation therapy
31 Recruiting PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Condition: Non Hodgkin Lymphoma
Interventions: Drug: enzastaurin;   Drug: placebo
32 Active, not recruiting Benign Prostatic Hyperplasia Trial With AVODART And Tamsulosin Combination Treatment
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: AVODART;   Drug: Tamsulosin
33 Not yet recruiting The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Conditions: Atherosclerosis;   Cardiovascular Disease;   Coronary Heart Disease;   CV Risk
Interventions: Drug: Darapladib;   Drug: Placebo
34 Completed Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer
Condition: Renal Cell Carcinoma
Intervention: Drug: autologous human tumor-derived HSPPC-96
35 Terminated Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
Condition: Carcinoma, Non-Small Cell Lung
Interventions: Drug: talabostat mesylate;   Drug: docetaxel
36 Recruiting A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Condition: Atopic Dermatitis
Intervention:
37 Active, not recruiting Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Condition: Breast Cancer
Interventions: Drug: raloxifene;   Drug: tamoxifen citrate
38 Active, not recruiting Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
Conditions: Brain and Central Nervous System Tumors;   Cancer-Related Problem/Condition
Interventions: Procedure: management of therapy complications;   Procedure: quality-of-life assessment
39 Enrolling by invitation IMMEDIATE Trial: Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care Trial
Conditions: Angina, Unstable;   Cardiovascular Diseases;   Heart Diseases;   Coronary Disease;   Myocardial Infarction;   Heart Failure, Congestive
Interventions: Drug: Glucose, Insulin and Potassium;   Drug: Dextrose 5%
40 Active, not recruiting "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
Condition: Prostate Cancer
Intervention: Drug: Dutasteride

Previous Page (1-20) Studies Shown (21-40) Next (41-60)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services